Plain-English translation of NCT07581496 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bladder Cancer research guide →This trial is investigating whether a blood test can detect traces of cancer DNA in patients with T1 grade 3 bladder cancer — a aggressive form that is difficult to predict and manage. Researchers will collect blood and urine samples from about 35 patients to build a research database that may help doctors identify which patients are at highest risk of cancer coming back or getting worse after their initial surgery.
Current methods for predicting which patients with this type of bladder cancer will do well or poorly are not reliable enough. This medication or test could help doctors tailor treatment plans more precisely, avoiding both under-treatment and unnecessary aggressive therapies, and ultimately improving outcomes.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will donate blood and urine samples at specified times before or after your bladder surgery. These samples will be stored in a research biobank for current and future testing to see if cancer DNA can be detected and whether it predicts your cancer's behavior. The study does not involve taking any medication — it is purely focused on collecting and analyzing your biological samples.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Switzerland